Figma's Shares Rise Amid Positive Analyst Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 09 2026
0mins
Should l Buy FIG?
Source: Fool
Figma Inc's shares increased by 5.02%, reaching a 5-day high, as investors reacted positively to recent analyst reports.
Despite a challenging market environment, analysts have expressed optimism regarding Figma's future, projecting a 12-month price target approximately 114% above the current share price. This confidence is bolstered by a reported 40% year-over-year revenue increase and a strong net dollar retention rate of 136% in Q4, indicating robust demand for its design software.
The positive sentiment from analysts suggests that Figma may be well-positioned to navigate the competitive landscape, particularly as it continues to integrate AI capabilities into its offerings, which could further enhance its market position.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FIG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FIG
Wall Street analysts forecast FIG stock price to rise
9 Analyst Rating
3 Buy
6 Hold
0 Sell
Moderate Buy
Current: 19.330
Low
38.00
Averages
53.13
High
70.00
Current: 19.330
Low
38.00
Averages
53.13
High
70.00
About FIG
Figma, Inc. designs and develops platforms for people who build digital products together. The Company helps cross-functional teams align and build software more efficiently and ensure the advanced access and controls that large organizations require. Its products include Figma Design, Dev Mode, Figma Sites, Figma Make, Figma Draw, Figma Buzz, FigJam and Figma Slides. Figma Sites is a product that lets clients design a Website and directly publish it to the Web, with a custom URL. Figma Make is an AI-powered tool that turns a prompt into a fully functional prototype. Figma Buzz is a product for easily creating marketing assets (like social media assets and digital ads) at a scale that is consistent with brand or visual identity. Figma Draw provides a space for finer vector editing required when drawing detailed iconography and product illustrations. Figma Design combines powerful features with a collaborative workspace to help teams design and build better products together.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Figma's Stock Plummets 83% Amid AI Disruption Concerns
- Stock Price Plunge: Figma's stock has fallen 83% since its IPO last July, despite the company continuing to deliver strong growth, reflecting market concerns over its valuation and the impact of AI competition, particularly from Anthropic's Claude Design, which poses a direct threat to its market position.
- Opportunity to Counter AI Narrative: Figma is set to report its first-quarter earnings on May 14, providing management with a chance to demonstrate to investors how the company is addressing the challenges posed by AI, especially after launching its own AI tools, which could alleviate market concerns about its future.
- Signs of Software Stock Recovery: Despite pressures on Figma, the broader software sector has rebounded over 20% in recent weeks after a sharp decline earlier this year, indicating that market fears regarding the software industry may have been exaggerated, which could benefit Figma.
- Potential for Earnings Beat: Figma has exceeded revenue estimates in all three of its earnings reports since going public, with a projected 38% growth for Q1; if it continues to beat estimates and raises its guidance, the stock could see significant gains, as its price-to-sales ratio of 10 remains reasonable for a fast-growing cloud company.
See More
Cerebras Sets IPO Price Range at $150-$160, Valuation Soars to $49 Billion
- IPO Price Range Increase: Cerebras has raised its IPO price range to $150-$160 per share, significantly up from $115-$125 last week, with the potential to raise up to $4.8 billion, indicating strong market interest in its unique AI chips.
- Significant Valuation Growth: At the new price range, Cerebras' valuation reaches approximately $49 billion, far exceeding its valuation from three months ago, reflecting investor optimism about its growth potential, especially in AI applications.
- Customer Concentration Risk: With 86% of revenue coming from just two customers, the high concentration poses financial instability risks, although the $20 billion agreement with OpenAI may help mitigate this, highlighting the need for caution in volatile markets.
- Market Volatility Warning: Given the high volatility of recent tech IPOs, investors should approach Cerebras' IPO with caution, considering a wait-and-see strategy or gradually building a position over several months to navigate potential market fluctuations.
See More
Pharmaceutical Stocks Rise Amid Hantavirus Outbreak
- Pharmaceutical Stocks Rise: Pharmaceutical stocks are climbing amid the recent hantavirus outbreak, although officials state that the public health risk is low, indicating strong market confidence in the pharmaceutical sector, which may drive stock prices higher for related companies.
- Oil Price Fluctuations: Oil futures rose overnight following Trump's rejection of Iran's peace proposal, as investors worry that prolonged conflict will further strain crude supply, potentially leading to instability in the energy market and impacting the profitability of related firms.
- Google Stock Surge: Alphabet's stock has climbed over 160% in the past 12 months, making it the best-performing trillion-dollar U.S. tech company, reflecting strong market confidence in its artificial intelligence capabilities, which may attract more investor interest.
- Target's New Strategy: Target has rolled out
See More
Pharmaceutical Stocks Rise Amid Hantavirus Outbreak
- Pharmaceutical Stocks Rise: Pharmaceutical stocks are climbing due to the recent hantavirus outbreak, although officials state that the public health risk is low, indicating increased market confidence in the pharmaceutical sector, which may drive stock prices higher.
- Oil Price Fluctuations: Oil prices rose overnight following Trump's rejection of Iran's peace proposal, as investors worry that prolonged conflict will further strain crude supply, potentially leading to instability in the energy market and affecting operational costs for related companies.
- Tech Stock Performance: Alphabet's stock has surged over 160% in the past 12 months, making it the best-performing trillion-dollar U.S. tech company, reflecting strong market confidence in its artificial intelligence capabilities, which may attract more investor interest in its future growth.
- Retail Strategy Adjustment: Target has opened
See More
Analysis of Investment Opportunities in Artificial Intelligence
- Figma Competitive Edge: Figma's net dollar retention rate reached 136% in Q4 2025, indicating a 36% increase in spending from long-term customers, and despite competition from lower-cost AI tools, it is likely to maintain loyalty among professional designers, thereby solidifying its market position.
- SentinelOne Revenue Growth: SentinelOne's annual recurring revenue (ARR) grew by 22% in Q4 of fiscal 2026, with an 18% increase among customers spending over $100,000, demonstrating strong demand despite challenges to confidence in cybersecurity, reflecting the effectiveness of its early AI integration.
- Meta Platforms Investment: Meta Platforms plans to raise capital expenditures to between $125 billion and $145 billion in 2026, and although this announcement caused a stock drop, its Q1 revenue grew by 33% year-over-year to $56.3 billion, indicating strong financial capacity for AI investments.
- Market Valuation Opportunities: With Figma's price-to-sales (P/S) ratio dropping to 9 and SentinelOne's at 5, both companies' significant stock price declines present investors with opportunities to enter AI-related stocks at relatively low prices, potentially leading to substantial recoveries in the future.
See More
Adobe Announces $25 Billion Share Buyback Program
- Buyback Program Size: Adobe has announced a substantial $25 billion share repurchase program, set to be completed by April 30, 2030, which represents nearly a quarter of its market capitalization of approximately $103 billion, reflecting the company's confidence in its future cash flow and long-term value.
- Strong Financial Performance: In the first quarter of fiscal 2026, Adobe reported revenue of $6.4 billion, a 12% year-over-year increase, with annualized recurring revenue (ARR) reaching $26.06 billion, up 10.9%, indicating robust core business performance despite competitive pressures from AI.
- Significant User Growth: Adobe's monthly active users exceeded 850 million, a 17% increase year-over-year, while ARR from its AI applications tripled, demonstrating strong customer engagement and appeal in emerging markets.
- Optimistic Future Outlook: Adobe projects full-year revenue between $25.9 billion and $26.1 billion, with adjusted earnings per share forecasted at $23.30 to $23.50, showcasing strong cash flow and profitability despite challenges in its traditional business segments.
See More
Figma's Stock Plummets 83% Amid AI Disruption Concerns
- Stock Price Plunge: Figma's stock has fallen 83% since its IPO last July, despite the company continuing to deliver strong growth, reflecting market concerns over its valuation and the impact of AI competition, particularly from Anthropic's Claude Design, which poses a direct threat to its market position.
- Opportunity to Counter AI Narrative: Figma is set to report its first-quarter earnings on May 14, providing management with a chance to demonstrate to investors how the company is addressing the challenges posed by AI, especially after launching its own AI tools, which could alleviate market concerns about its future.
- Signs of Software Stock Recovery: Despite pressures on Figma, the broader software sector has rebounded over 20% in recent weeks after a sharp decline earlier this year, indicating that market fears regarding the software industry may have been exaggerated, which could benefit Figma.
- Potential for Earnings Beat: Figma has exceeded revenue estimates in all three of its earnings reports since going public, with a projected 38% growth for Q1; if it continues to beat estimates and raises its guidance, the stock could see significant gains, as its price-to-sales ratio of 10 remains reasonable for a fast-growing cloud company.
See More
Cerebras Sets IPO Price Range at $150-$160, Valuation Soars to $49 Billion
- IPO Price Range Increase: Cerebras has raised its IPO price range to $150-$160 per share, significantly up from $115-$125 last week, with the potential to raise up to $4.8 billion, indicating strong market interest in its unique AI chips.
- Significant Valuation Growth: At the new price range, Cerebras' valuation reaches approximately $49 billion, far exceeding its valuation from three months ago, reflecting investor optimism about its growth potential, especially in AI applications.
- Customer Concentration Risk: With 86% of revenue coming from just two customers, the high concentration poses financial instability risks, although the $20 billion agreement with OpenAI may help mitigate this, highlighting the need for caution in volatile markets.
- Market Volatility Warning: Given the high volatility of recent tech IPOs, investors should approach Cerebras' IPO with caution, considering a wait-and-see strategy or gradually building a position over several months to navigate potential market fluctuations.
See More
Pharmaceutical Stocks Rise Amid Hantavirus Outbreak
- Pharmaceutical Stocks Rise: Pharmaceutical stocks are climbing amid the recent hantavirus outbreak, although officials state that the public health risk is low, indicating strong market confidence in the pharmaceutical sector, which may drive stock prices higher for related companies.
- Oil Price Fluctuations: Oil futures rose overnight following Trump's rejection of Iran's peace proposal, as investors worry that prolonged conflict will further strain crude supply, potentially leading to instability in the energy market and impacting the profitability of related firms.
- Google Stock Surge: Alphabet's stock has climbed over 160% in the past 12 months, making it the best-performing trillion-dollar U.S. tech company, reflecting strong market confidence in its artificial intelligence capabilities, which may attract more investor interest.
- Target's New Strategy: Target has rolled out
See More
Pharmaceutical Stocks Rise Amid Hantavirus Outbreak
- Pharmaceutical Stocks Rise: Pharmaceutical stocks are climbing due to the recent hantavirus outbreak, although officials state that the public health risk is low, indicating increased market confidence in the pharmaceutical sector, which may drive stock prices higher.
- Oil Price Fluctuations: Oil prices rose overnight following Trump's rejection of Iran's peace proposal, as investors worry that prolonged conflict will further strain crude supply, potentially leading to instability in the energy market and affecting operational costs for related companies.
- Tech Stock Performance: Alphabet's stock has surged over 160% in the past 12 months, making it the best-performing trillion-dollar U.S. tech company, reflecting strong market confidence in its artificial intelligence capabilities, which may attract more investor interest in its future growth.
- Retail Strategy Adjustment: Target has opened
See More
Analysis of Investment Opportunities in Artificial Intelligence
- Figma Competitive Edge: Figma's net dollar retention rate reached 136% in Q4 2025, indicating a 36% increase in spending from long-term customers, and despite competition from lower-cost AI tools, it is likely to maintain loyalty among professional designers, thereby solidifying its market position.
- SentinelOne Revenue Growth: SentinelOne's annual recurring revenue (ARR) grew by 22% in Q4 of fiscal 2026, with an 18% increase among customers spending over $100,000, demonstrating strong demand despite challenges to confidence in cybersecurity, reflecting the effectiveness of its early AI integration.
- Meta Platforms Investment: Meta Platforms plans to raise capital expenditures to between $125 billion and $145 billion in 2026, and although this announcement caused a stock drop, its Q1 revenue grew by 33% year-over-year to $56.3 billion, indicating strong financial capacity for AI investments.
- Market Valuation Opportunities: With Figma's price-to-sales (P/S) ratio dropping to 9 and SentinelOne's at 5, both companies' significant stock price declines present investors with opportunities to enter AI-related stocks at relatively low prices, potentially leading to substantial recoveries in the future.
See More
Adobe Announces $25 Billion Share Buyback Program
- Buyback Program Size: Adobe has announced a substantial $25 billion share repurchase program, set to be completed by April 30, 2030, which represents nearly a quarter of its market capitalization of approximately $103 billion, reflecting the company's confidence in its future cash flow and long-term value.
- Strong Financial Performance: In the first quarter of fiscal 2026, Adobe reported revenue of $6.4 billion, a 12% year-over-year increase, with annualized recurring revenue (ARR) reaching $26.06 billion, up 10.9%, indicating robust core business performance despite competitive pressures from AI.
- Significant User Growth: Adobe's monthly active users exceeded 850 million, a 17% increase year-over-year, while ARR from its AI applications tripled, demonstrating strong customer engagement and appeal in emerging markets.
- Optimistic Future Outlook: Adobe projects full-year revenue between $25.9 billion and $26.1 billion, with adjusted earnings per share forecasted at $23.30 to $23.50, showcasing strong cash flow and profitability despite challenges in its traditional business segments.
See More
